Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00029159 · ClinicalTrials.gov registry record · Phase 3
The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome
A Phase 3 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
NCT00029159 is a Phase 3 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 200 participants.
The verdict
NCT00029159, a Phase 3 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purposes of this study are to learn whether treatment with an androgen type hormone will improve the visual-spatial problems associated with Turner syndrome, and to evaluate the effect growth hormone, with and without androgen, has on growth.
Interventions
- OTHER placebo
- DRUG estrogen
- DRUG androgen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 1992-11 |
| Est. Completion | 2012-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00029159
The ClinicalTrials.gov registry entry for NCT00029159 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00029159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00029159 about?
NCT00029159 is a clinical study titled "The Effect of Androgen and Growth Hormone on Height and Learning in Girls With Turner Syndrome". The purposes of this study are to learn whether treatment with an androgen type hormone will improve the visual-spatial problems associated with Turner syndrome, and to evaluate the effect growth hormone, with and without androgen, has on growth.
What is the current status of trial NCT00029159?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 1992-11. Estimated completion is 2012-06.
What interventions are being tested in trial NCT00029159?
The interventions under investigation include: placebo (OTHER), estrogen (DRUG), androgen (DRUG).
Who is sponsoring clinical trial NCT00029159?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.